ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.040
-0.060 (-5.45%)
May 20, 2026, 3:08 PM EDT - Market open
ABVC BioPharma Employees
As of December 31, 2025, ABVC BioPharma had 19 total employees, including 16 full-time and 3 part-time employees. The number of employees did not change compared to the previous year.
Employees
19
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$454,038
Market Cap
25.70M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 19 | 0 | - | 16 | 3 |
| Dec 31, 2024 | 19 | 0 | - | 16 | 3 |
| Dec 31, 2023 | 19 | -4 | -17.39% | 16 | 3 |
| Dec 31, 2022 | 23 | -7 | -23.33% | 19 | 4 |
| Dec 31, 2021 | 30 | -4 | -11.76% | 28 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 59 |
| Werewolf Therapeutics | 39 |
| Kyntra Bio | 34 |
| Palatin Technologies | 29 |
| Barinthus Biotherapeutics | 14 |
| Skye Bioscience | 12 |
| Neuphoria Therapeutics | 8 |
| Traws Pharma | 7 |
ABVC News
- 2 days ago - ABVC BioPharma Quarterly report: Q1 2026 - Filings
- 2 months ago - ABVC BioPharma Proxy statement: Proxy Filing - Filings
- 2 months ago - ABVC BioPharma Annual report: Q4 2025 - Filings
- 3 months ago - ABVC BioPharma Proxy statement: Proxy Filing - Filings
- 7 months ago - ABVC BioPharma Earnings release: Q3 2025 - Filings
- 7 months ago - ABVC BioPharma Quarterly report: Q3 2025 - Filings
- 10 months ago - ABVC BioPharma Earnings release: Q2 2025 - Filings
- 10 months ago - ABVC BioPharma Quarterly report: Q2 2025 - Filings